Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations.

"Financial support for this project was provided by CHOP Frontiers Program Immune Dysregulation Team (D.T.T., E.M.B., and H.B.), National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (R01AI121250 [E.M.B.]; R01AI103280, R01AI123433, and R21AI144472 [A.R.O.J.]; K08 AI136660 [L.A.V.]; and K08AI135091 [S. E. Henrickson]), NIH/National Cancer Institute (R01CA193776, X01HD100702-01, 5UG1CA233249, and R01A1123538) (D.T.T.), the Leukemia and Lymphoma Society (D.T.T.), Cookies for Kids Cancer (D.T.T.), Alex’s Lemonade Stand Foundation for Childhood Cancer (D.T.T.), Children’s Oncology Group (D.T.T.), Stand UP 2 Cancer (D.T.T.), Team Connor Childhood Cancer Foundation (H.B.), Burroughs Wellcome Fund CAMS (S. E. Henrickson and A.R.O.J.), Clinical Immunology Society (S. E. Henrickson), the American Academy of Allergy, Asthma, and Immunology (S. E. Henrickson), and the Agency for Healthcare Research and Quality (K12HS026393) (K.C.). C.D. is supported by an Institute for Translation Medicine and Therapheutics (ITMAT) scholarship and by the CHOP Gail Slap Fellowship Award. A.M.B. is supported by NIH/National Institute of General Medical Sciences (T32-GM075766). J.C.F. is supported by NIH/National Institute of Diabetes and Digestive and Kidney Diseases (K23DK119463). E.M.A. was supported by the NIH Training in Virology T32 Program (T32-AI-007324)."